Teva Canada announces new General Manager, Michael Sine

After 4 years leading the Teva organization in Canada, General Manager, Christine Poulin, has decided to pursue new opportunities. We are pleased to announce that effective July 27, 2022 Michael Sine, Vice President Sales and Marketing for Generics and OTC, will take on the role of General Manager of Teva Canada. 

Message from Teva Canada’s NEW General Manager | Michael Sine

I have had the pleasure of collaborating with Christine for many years and wish her the best as she moves on to new experiences.

Having spent decades building relationships with our customers and stakeholders, as well as with our internal teams, I am excited to broaden my role at Teva Canada. This new role allows me to continue working closely with the Healthcare Professional (HCP) community in Canada but in an expanded capacity. I look forward to what new opportunities await.

It will be a privilege to lead our respected teams as they continue to work together as One Teva across all business units: Generics, OTC, Specialty and Biosimilars. These teams are comprised of solid leaders in all functional areas, each with unique and extensive industry strengths which create a synergy we leverage to benefit our Healthcare Professional partners. At our core, our focus remains on you, our Healthcare Professional partners as well as the patients that rely on our medicines.

Thank you for your partnership and we look forward to continuous progress in 2022 and beyond.

Michael Sine